Financial statements Fibiomed
Balance sheet data of FIBIOMED
|
Year
|
2020
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 2 452 613,93 | 639 412,87 | 865 758,01 |
| A. Fixed assets | 2 734,29 | 27 257,79 | 57 845,08 |
| B. Current assets | 2 449 879,64 | 612 155,08 | 807 912,93 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 452 613,93 | 639 412,87 | 865 758,01 |
| A. Equity | 1 125 726,83 | 439 254,02 | -675 087,86 |
| B. Liabilities and provisions for liabilities | 1 326 887,10 | 200 158,85 | 1 540 845,87 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 162 596,40 | 162 716,48 | 1 496 824,43 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.